KM Biologics President Nagasato
Toshiaki Nagasato, president of KM Biologics Co., gives an interview to Kyodo News in the southwestern Japan city of Kumamoto on Nov. 7, 2022. The Japanese pharmaceuticals company is developing a domestic COVID-19 vaccine.
- Product Code
- ILEA001054931
- Registered date
- 2022/11/08 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media source
- 2022 Kyodo News
- Media size
- 2649 × 2179 pixel
- Deployment size
- 577.77(KB)*
*File size when opened in Photoshop, etc.